W Ted Love

Affiliations

  • President And Ceo at Global Blood Therapeutics Inc. (GBT), 2021-03-04
  • Director at Seattle Genetics Inc (SGEN), 2020-08-18
  • Director at Royalty Pharma Plc (RPRX), 2020-08-18
  • Director at Portola Pharmaceuticals Inc (PTLA), 2020-07-02
  • Director at Amicus Therapeutics Inc. (FOLD), 2020-06-08
  • Director at Cascadian Therapeutics Inc. (CASC), 2018-03-13
  • Director at Kalobios Pharmaceuticals Inc (KBIO), 2015-07-14
  • Director at Santarus Inc (SNTS), 2014-01-06
  • Director at Mast Therapeutics Inc. (MSTX), 2013-06-21
  • Evp, R&d And Tech. Operations at Onyx Pharmaceuticals Inc (ONXX), 2012-07-28
  • Director at Affymax Inc (AFFY), 2012-06-18
  • Director at Bio Rad Laboratories Inc (BIO, BIO.B), 2010-03-25
  • Director at Arca Biopharma Inc. (ABIO), 2010-02-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CASC $4.24 23,000 Director 27,209 2017-02-02 Filing
GBT $20.00 2,500 Officer, Director 2,500 2015-08-17 Filing
GBT $20.00 2,500 Officer, Director 2,500 2015-08-17 Filing
GBT $20.00 5,000 Officer, Director 1,140,711 2015-08-17 Filing
SNTS $10.88 185,000 Director 335,500 2012-12-18 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GBT $80.00 40,000 Officer, Director 1,034,633 2020-04-28 Filing
GBT $80.63 1,517 Officer, Director 1,074,633 2020-04-27 Filing
GBT $81.15 1,300 Officer, Director 1,076,150 2020-04-27 Filing
GBT $70.92 1,818 Officer, Director 1,077,450 2020-02-18 Filing
GBT $70.22 2,189 Officer, Director 1,079,268 2020-02-18 Filing